Cfo4 Life Group, LLC Brainstorm Cell Therapeutics Inc. Transaction History

Cfo4 Life Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	SELL	$2.71 - $3.6 $32,520 - $43,200	-12,000 Closed	0 $0
Q3 2021 Oct 12, 2021	SELL	$3.14 - $4.09 $9 - $12	-3 Reduced 0.02%	12,000 $40,000
Q2 2020 Jul 15, 2020	BUY	$4.42 - $12.66 $13 - $37	3 Added 0.03%	12,003 $135,000
Q4 2019 Jan 22, 2020	BUY	$3.62 - $4.29 $43,440 - $51,480	12,000 New	12,000 $51,000

10.9M

160K

30.5K

Ticker BCLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,486,200
Market Cap $39.4M
Description
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...

Get notified when there are updates to the investment portfolio of Cfo4 Life Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Cfo4 Life Group, LLC with notifications on news.